295 related articles for article (PubMed ID: 25519448)
1. Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes.
Davis AK; DuBose SN; Haller MJ; Miller KM; DiMeglio LA; Bethin KE; Goland RS; Greenberg EM; Liljenquist DR; Ahmann AJ; Marcovina SM; Peters AL; Beck RW; Greenbaum CJ;
Diabetes Care; 2015 Mar; 38(3):476-81. PubMed ID: 25519448
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of preserved insulin secretion in children and adolescents with type 1 diabetes].
Wegner O; Wyka K; Fendler W; Zmysłowska A; Młynarski W
Pediatr Endocrinol Diabetes Metab; 2010; 16(2):67-71. PubMed ID: 20813081
[TBL] [Abstract][Full Text] [Related]
3. [C-peptide residual secretion makes difference on type 1 diabetes management?].
Rodacki M; Milech A; Oliveira JE
Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):322-33. PubMed ID: 18438543
[TBL] [Abstract][Full Text] [Related]
4. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
Picardi A; Visalli N; Lauria A; Suraci C; Buzzetti R; Merola MK; Manfrini S; Guglielmi C; Gentilucci UV; Pitocco D; Crinò A; Bizzarri C; Cappa M; Pozzilli P
Horm Metab Res; 2006 Oct; 38(10):668-72. PubMed ID: 17075776
[TBL] [Abstract][Full Text] [Related]
5. PRESERVED PROINSULIN SECRETION IN LONG-STANDING TYPE 1 DIABETES.
Steenkamp DW; Cacicedo JM; Sahin-Efe A; Sullivan C; Sternthal E
Endocr Pract; 2017 Dec; 23(12):1387-1393. PubMed ID: 29144809
[TBL] [Abstract][Full Text] [Related]
6. Characterization of residual β cell function in long-standing type 1 diabetes.
Sherr JL; Ghazi T; Wurtz A; Rink L; Herold KC
Diabetes Metab Res Rev; 2014 Feb; 30(2):154-62. PubMed ID: 24115337
[TBL] [Abstract][Full Text] [Related]
7. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
Hao W; Gitelman S; DiMeglio LA; Boulware D; Greenbaum CJ;
Diabetes Care; 2016 Oct; 39(10):1664-70. PubMed ID: 27422577
[TBL] [Abstract][Full Text] [Related]
8. An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes.
Buchanan K; Mehdi AM; Hughes I; Cotterill A; Le Cao KA; Thomas R; Harris M
Pediatr Diabetes; 2019 Mar; 20(2):166-171. PubMed ID: 30556344
[TBL] [Abstract][Full Text] [Related]
9. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells.
Oram RA; Jones AG; Besser RE; Knight BA; Shields BM; Brown RJ; Hattersley AT; McDonald TJ
Diabetologia; 2014 Jan; 57(1):187-91. PubMed ID: 24121625
[TBL] [Abstract][Full Text] [Related]
10. Residual C-peptide in type 1 diabetes: what do we really know?
VanBuecken DE; Greenbaum CJ
Pediatr Diabetes; 2014 Mar; 15(2):84-90. PubMed ID: 24645775
[TBL] [Abstract][Full Text] [Related]
11. Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors.
Oram RA; McDonald TJ; Shields BM; Hudson MM; Shepherd MH; Hammersley S; Pearson ER; Hattersley AT;
Diabetes Care; 2015 Feb; 38(2):323-8. PubMed ID: 25519449
[TBL] [Abstract][Full Text] [Related]
12. Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes.
McKeigue PM; Spiliopoulou A; McGurnaghan S; Colombo M; Blackbourn L; McDonald TJ; Onengut-Gomuscu S; Rich SS; A Palmer CN; McKnight JA; J Strachan MW; Patrick AW; Chalmers J; Lindsay RS; Petrie JR; Thekkepat S; Collier A; MacRury S; Colhoun HM
BMC Med; 2019 Aug; 17(1):165. PubMed ID: 31438962
[TBL] [Abstract][Full Text] [Related]
13. The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
Marcovecchio ML; Hendriks AEJ; Delfin C; Battelino T; Danne T; Evans ML; Johannesen J; Kaur S; Knip M; Overbergh L; Pociot F; Todd JA; Van der Schueren B; Wicker LS; Peakman M; Mathieu C;
Diabetologia; 2024 Jun; 67(6):995-1008. PubMed ID: 38517484
[TBL] [Abstract][Full Text] [Related]
14. Residual
Lin K; Yang X; Wu Y; Chen S; Zeng Q
J Diabetes Res; 2021; 2021():9946874. PubMed ID: 34258294
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
Barker A; Lauria A; Schloot N; Hosszufalusi N; Ludvigsson J; Mathieu C; Mauricio D; Nordwall M; Van der Schueren B; Mandrup-Poulsen T; Scherbaum WA; Weets I; Gorus FK; Wareham N; Leslie RD; Pozzilli P
Diabetes Obes Metab; 2014 Mar; 16(3):262-7. PubMed ID: 24118704
[TBL] [Abstract][Full Text] [Related]
16. Insulin micro-secretion in Type 1 diabetes and related microRNA profiles.
Januszewski AS; Cho YH; Joglekar MV; Farr RJ; Scott ES; Wong WKM; Carroll LM; Loh YW; Benitez-Aguirre PZ; Keech AC; O'Neal DN; Craig ME; Hardikar AA; Donaghue KC; Jenkins AJ
Sci Rep; 2021 Jun; 11(1):11727. PubMed ID: 34083567
[TBL] [Abstract][Full Text] [Related]
17. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes.
Sims EK; Bahnson HT; Nyalwidhe J; Haataja L; Davis AK; Speake C; DiMeglio LA; Blum J; Morris MA; Mirmira RG; Nadler J; Mastracci TL; Marcovina S; Qian WJ; Yi L; Swensen AC; Yip-Schneider M; Schmidt CM; Considine RV; Arvan P; Greenbaum CJ; Evans-Molina C;
Diabetes Care; 2019 Feb; 42(2):258-264. PubMed ID: 30530850
[TBL] [Abstract][Full Text] [Related]
18. [Residual insulin secretion in juvenile diabetes. Relationships with duration of diabetes, metabolic control and retinopathy (author's transl)].
Dorchy H; Despontin M; Haumont D; Toussaint D; Loeb H
Arch Fr Pediatr; 1982 Mar; 39(3):145-8. PubMed ID: 7049110
[TBL] [Abstract][Full Text] [Related]
19. Circulating adiponectin concentration is inversely associated with glucose tolerance and insulin secretion in people with newly diagnosed diabetes.
Weber KS; Strassburger K; Pacini G; Nowotny B; Müssig K; Szendroedi J; Herder C; Roden M;
Diabet Med; 2017 Feb; 34(2):239-244. PubMed ID: 27770592
[TBL] [Abstract][Full Text] [Related]
20. Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses.
Harsunen M; Haukka J; Harjutsalo V; Mars N; Syreeni A; Härkönen T; Käräjämäki A; Ilonen J; Knip M; Sandholm N; Miettinen PJ; Groop PH; Tuomi T
Lancet Diabetes Endocrinol; 2023 Jul; 11(7):465-473. PubMed ID: 37290465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
